0000939767-17-000079.txt : 20170510
0000939767-17-000079.hdr.sgml : 20170510
20170510200746
ACCESSION NUMBER: 0000939767-17-000079
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170508
FILED AS OF DATE: 20170510
DATE AS OF CHANGE: 20170510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: EXELIXIS, INC.
CENTRAL INDEX KEY: 0000939767
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043257395
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6508377000
MAIL ADDRESS:
STREET 1: 210 E. GRAND AVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS INC
DATE OF NAME CHANGE: 20000207
FORMER COMPANY:
FORMER CONFORMED NAME: EXELIXIS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20000106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRISSEY MICHAEL
CENTRAL INDEX KEY: 0001202096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30235
FILM NUMBER: 17832042
MAIL ADDRESS:
STREET 1: C/O EXELIXIS INC
STREET 2: 170 HARBOR WAY
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94083
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL M
DATE OF NAME CHANGE: 20030512
FORMER NAME:
FORMER CONFORMED NAME: MORRISSEY MICHAEL R
DATE OF NAME CHANGE: 20021029
4
1
wf-form4_149446125113476.xml
FORM 4
X0306
4
2017-05-08
0
0000939767
EXELIXIS, INC.
EXEL
0001202096
MORRISSEY MICHAEL
C/O EXELIXIS, INC.
210 E. GRAND AVE.
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President and CEO
Common Stock
2017-05-08
4
M
0
11300
1.90
A
71300
D
Common Stock
2017-05-08
4
S
0
11300
21.81
D
60000
D
Common Stock
2017-05-09
4
M
0
51214
1.90
A
111214
D
Common Stock
2017-05-09
4
S
0
51214
21.77
D
60000
D
Common Stock
2017-05-09
4
M
0
48786
1.90
A
108786
D
Common Stock
2017-05-09
4
S
0
48786
21.60
D
60000
D
Common Stock
2017-05-10
4
M
0
79551
1.90
A
139551
D
Common Stock
2017-05-10
4
M
0
20449
1.70
A
160000
D
Common Stock
2017-05-10
4
S
0
100000
22.07
D
60000
D
Common Stock
172698
I
By Trust
Common Stock
17018
I
By 401(k)
Option (right to buy)
1.9
2017-05-08
4
M
0
11300
0
D
2015-07-20
2022-02-04
Common Stock
11300.0
179551
D
Option (right to buy)
1.9
2017-05-09
4
M
0
51214
0
D
2015-07-20
2022-02-04
Common Stock
51214.0
128337
D
Option (right to buy)
1.9
2017-05-09
4
M
0
48786
0
D
2015-07-20
2022-02-04
Common Stock
48786.0
79551
D
Option (right to buy)
1.9
2017-05-10
4
M
0
79551
0
D
2015-07-20
2022-02-04
Common Stock
79551.0
0
D
Option (right to buy)
1.7
2017-05-10
4
M
0
20449
0
D
2015-07-20
2021-09-18
Common Stock
20449.0
1104551
D
Includes 60,000 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.80 to $21.84. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.75 to $21.80. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.60 to $21.61. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $22.00 to $22.15. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.
Shares held by Michael M. Morrissey and Meghan D. Morrissey, Trustees of the Morrissey Family Living Trust dated July 21, 1994, as amended.
Represents 17,018 shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 8, 2017.
The option, representing the right to purchase a total of 450,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016.
The option, representing the right to purchase a total of 1,125,000 shares of Exelixis, Inc. common stock, became exercisable as to fifty percent (50%) of the shares subject to the option on July 20, 2015, as to twenty-five (25%) of the shares subject to the option on March 7, 2016 and as to the remaining twenty-five (25%) of the shares subject to the option on April 28, 2016.
/s/ Jeffrey J. Hessekiel, Attorney in Fact
2017-05-10